RxDoctor Payments Data

Michael McIver, MD

Physical Medicine & Rehabilitation · Lafayette, LANPI 1912386814

Payments from drug & device makers

What this record shows

23 manufacturers reported payments, led by Boston Scientific at 35.6% of the total. 2025 is the largest year on record at $2,644, 2.5 times the $1,042 reported in 2019.

$5,477in general payments, 2019–2025

Across 107 payments — averaging $51.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$1K
  • Saluda Medical Americas, Inc.$470
  • Si-bone, Inc.$392
  • Merz Pharmaceuticals, LLC$319
  • AbbVie$275
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$2,47145%
  • Food & beverage$3,00655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,477 in reported general payments places this provider in the 85th percentile of 117 physical medicine & rehabilitation providers in Louisiana.

See all physical medicine & rehabilitation providers in Louisiana

Medicare billing

Part B allowed, 2024
$163,897
Medicare patients
200
Services billed
11,968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin350$11,327
Gabapentin670$8,158
Diclofenac Sodium354$7,129
Celecoxib168$5,111
Metaxalone13$4,035
Methocarbamol168$2,308
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen176$1,793
Baclofen75$1,537
Tizanidine Hcl150$1,394
Cyclobenzaprine Hcl88$873
Nabumetone35$810
Clonidine11$792
Meloxicam212$536
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$389
Amitriptyline Hcl18$252

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →